Actavis on Friday confirmed that it has filed an abbreviated new drug application with the Food and Drug Administration to market buprenorphine transdermal system, a generic version of Butrans from Purdue Pharma.
Members of the Global Market Development Center attended more than 8,000 scheduled meetings in the span of five days at the 2014 General Merchandise Marketing Conference held in San Antonio from Sept. 5 to 9, GMDC has announced.
Celgene Corp. earlier this week announced that the Food and Drug Administration approved Otezla (apremilast) for the treatment of moderate to severe plaque psoriasis. The drug is the first and only PDE4 inhibitor approved for the treatment of plaque psoriasis, according to the company.
AbbVie on Thursday announced that the Food and Drug Administration approved Humira (adalimumab) as a treatment for pediatric Crohn's disease patients ages 6 years and older when other treatments haven't worked well enough.
Pfizer announced on Thursday that it has completed its acquisition of the pharmaceutical development company, InnoPharma, following receipt of U.S. regulatory approval from all government authorities required by the agreement and other closing conditions.